Two SmDLC antigens as potential vaccines against schistosomiasis

Acta Tropica

Volumn 140, Issue , 2014, Pages 193-201

  Diniz, Patricia Placoná ^a   Nakajima, Erika ^a   Miyasato, Patricia Aoki ^a   Nakano, Eliana ^a   de Oliveira Rocha, Márcia ^a   Martins, Elizabeth Angelica Leme ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Dynein light chain; Granuloma; Schistosomiasis; Vaccine

Indexed keywords

ALUMINUM HYDROXIDE; DYNEIN ADENOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT DYNEIN LIGHT CHAIN 12; RECOMBINANT DYNEIN LIGHT CHAIN 13; SCHISTOSOMA VACCINE; UNCLASSIFIED DRUG; DNA VACCINE; PARASITE ANTIGEN;

ANTIBODY; ANTIGEN; IMMUNITY; IMMUNIZATION; PROTEIN; SCHISTOSOMIASIS; VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CERCARIA; CONTROLLED STUDY; CROSS REACTION; FEMALE; GENE EXPRESSION; IMMUNOGENICITY; LIVER GRANULOMA; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE LOAD; PURIFICATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TRANSCRIPTOMICS; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; VACCINATION;

ANIMALS; ANTIGENS, HELMINTH; FEMALE; MICE; MICE, INBRED BALB C; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINATION; VACCINES, DNA;

EID: 84908458034     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2014.09.006     Document Type: Article

References (45)

1. Abath F.G., Morais C.N., Montenegro C.E., Wynn T.A., Montenegro S.M. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies?. Trends Parasitol. 2006, 22:85-91.
2. Ahmad G., Zhang W., Torben W., Ahrorov A., Damian R.T., Wolf R.F., White G.L., Carey D.W., Mwinzi P.N., Ganley-Leal L., Kennedy R.C., Siddiqui A.A. Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J. Infect. Dis. 2011, 204:1437-1449.
3. Amábile-Cuevas C.F., Demple B. Molecular characterization of the soxRS genes of Escherichia coli: two genes control a superoxide stress regulon. Nucleic Acids Res. 1991, 19:4479-4484.
4. Argiro L., Henri S., Dessein H., Kouriba B., Dessein A.J., Bourgois A. Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum. Vaccine 2000, 18:2033-2038.
5. Bickle Q.D., Bøgh H.O., Johansen M.V., Zhang Y. Comparison of the vaccine efficacy of gamma-irradiated Schistosoma japonicum cercariae with the defined antigen Sj62(IrV-5) in pigs. Vet. Parasitol. 2001, 100:51-62.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Braschi S., Curwen R.S., Ashton P.D., Verjovski-Almeida S., Wilson A. The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 2006, 6:1471-1482.
8. Braschi S., Wilson R.A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol. Cell. Proteomics 2006, 5:347-356.
9. Cardoso F.C., Pinho J.M., Azevedo V., Oliveira S.C. Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis. Genet. Mol. Res. 2006, 5:609-618.
10. Chuah C., Jones M.K., Burke M.L., McManus D.P., Gobert G.N. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014, 30:141-150.
11. Chura-Chambi R.M., Nakajima E., de Carvalho R.R., Miyasato P.A., Oliveira S.C., Morganti L., Martins E.A. Refolding of the recombinant protein Sm29, a step towards the production of the vaccine candidate against schistosomiasis. J. Biotechnol. 2013, 168:511-519.
12. Curti E., Kwityn C., Zhan B., Gillespie P., Brelsford J., Deumic V., Plieskatt J., Rezende W.C., Tsao E., Kalampanayil B., Hotez P.J., Bottazzi M.E. Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal schistosomiasis. Hum. Vaccin. Immunother. 2013, 9:2342-2350.
13. Fitzsimmons C.M., Jones F.M., Stearn A., Chalmers I.W., Hoffmann K.F., Wawrzyniak J., Wilson S., Kabatereine N.B., Dunne D.W. The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses. PLoS Negl. Trop. Dis. 2012, 6:e1593.
14. Fitzsimmons C.M., McBeath R., Joseph S., Jones F.M., Walter K., Hoffmann K.F., Kariuki H.C., Mwatha J.K., Kimani G., Kabatereine N.B., Vennervald B.J., Ouma J.H., Dunne D.W. Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: molecular structure and patterns of in vivo exposure. Int. Arch. Allergy Immunol. 2007, 142:40-50.
15. Fitzsimmons C.M., Stewart T.J., Hoffmann K.F., Grogan J.L., Yazdanbakhsh M., Dunne D.W. Human IgE response to the Schistosoma haematobium 22.6kDa antigen. Parasite Immunol. 2004, 26:371-376.
16. Githui E.K., Damian R.T., Aman R.A., Ali M.A., Kamau J.M. Schistosoma spp.: isolation of microtubule associated proteins in the tegument and the definition of dynein light chains components. Exp. Parasitol. 2009, 121:96-104.
17. Hoffmann K.F., Strand M. Molecular identification of a Schistosoma mansoni tegumental protein with similarity to cytoplasmic dynein light chains. J. Biol. Chem. 1996, 271:26117-26123.
18. Hoffmann K.F., Strand M. Molecular characterization of a 20.8-kDa Schistosoma mansoni antigen. Sequence similarity to tegumental associated antigens and dynein light chains. J. Biol. Chem. 1997, 272:14509-14515.
19. Inal J., Bickle Q. Sequence and immunogenicity of the 23-kDa transmembrane antigen of Schistosoma haematobium. Mol. Biochem. Parasitol. 1995, 74:217-221.
20. Jones M.K., Gobert G.N., Zhang L., Sunderland P., McManus D.P. The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioessays 2004, 26:752-765.
21. Karmakar S., Zhang W., Ahmad G., Torben W., Alam M.U., Le L., Damian R.T., Wolf R.F., White G.L., Carey D.W., Carter D., Reed S.G., Siddiqui A.A. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine 2014, 32:1296-1303.
22. Kohlstädt S., Couissinier-Paris P., Bourgois A., Bouchon B., Piper K., Kolbe H., Dessein A.J. Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans. Mol. Biochem. Parasitol. 1997, 84:155-165.
23. Liang J., Jaffrey S.R., Guo W., Snyder S.H., Clardy J. Structure of the PIN/LC8 dimer with a bound peptide. Nat. Struct. Biol. 1999, 6:735-740.
24. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 2008, 21:225-242.
25. Pearce E.J., James S.L., Hieny S., Lanar D.E., Sher A. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5678-5682.
26. Ramos C.R., Abreu P.A., Nascimento A.L., Ho P.L. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz. J. Med. Biol. Res. 2004, 37:1103-1109.
27. Ramos C.R., Vilar M.M., Nascimento A.L., Ho P.L., Thaumaturgo N., Edelenyi R., Almeida M., Dias W.O., Diogo C.M., Tendler M. r-Sm14 - pRSETA efficacy in experimental animals. Mem. Inst. Oswaldo Cruz 2001, 96(Suppl.):131-135.
28. Rezende C.M., Silva M.R., Santos I.G., Silva G.A., Gomes D.A., Goes A.M. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production. Immunol. Lett. 2011, 141:123-133.
29. Riveau G., Deplanque D., Remoué F., Schacht A.M., Vodougnon H., Capron M., Thiry M., Martial J., Libersa C., Capron A. Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl. Trop. Dis. 2012, 6:e1704.
30. Smithers S.R., Terry R.J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 1965, 55:695-700.
31. Soisson L.M., Masterson C.P., Tom T.D., McNally M.T., Lowell G.H., Strand M. Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J. Immunol. 1992, 149:3612-3620.
32. Tendler M., Simpson A.J. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Acta Trop. 2008, 108:263-266.
33. Tran M.H., Pearson M.S., Bethony J.M., Smyth D.J., Jones M.K., Duke M., Don T.A., McManus D.P., Correa-Oliveira R., Loukas A. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat. Med. 2006, 12:835-840.
34. Utzinger J., Becker S.L., Knopp S., Blum J., Neumayr A.L., Keiser J., Hatz C.F. Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med. Wkly. 2012, 142:w13727.
35. Van Hellemond J.J., Retra K., Brouwers J.F., van Balkom B.W., Yazdanbakhsh M., Shoemaker C.B., Tielens A.G. Functions of the tegument of schistosomes: clues from the proteome and lipidome. Int. J. Parasitol. 2006, 36:691-699.
36. Verjovski-Almeida S., DeMarco R., Martins E.A., Guimaraes P.E., Ojopi E.P., Paquola A.C., Piazza J.P., Nishiyama M.Y., Kitajima J.P., Adamson R.E., Ashton P.D., Bonaldo M.F., Coulson P.S., Dillon G.P., Farias L.P., Gregorio S.P., Ho P.L., Leite R.A., Malaquias L.C., Marques R.C., Miyasato P.A., Nascimento A.L., Ohlweiler F.P., Reis E.M., Ribeiro M.A., Sa R.G., Stukart G.C., Soares M.B., Gargioni C., Kawano T., Rodrigues V., Madeira A.M., Wilson R.A., Menck C.F., Setubal J.C., Leite L.C., Dias-Neto E. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat. Genet. 2003, 35:148-157.
37. Wilson M.S., Mentink-Kane M.M., Pesce J.T., Ramalingam T.R., Thompson R., Wynn T.A. Immunopathology of schistosomiasis. Immunol. Cell Biol. 2007, 85:148-154.
38. WHO The Social Context of Schistosomiasis and Its Control: An Introduction and Annotated Bibliography 2008, World Health Organization on be-half of the Special Programme for Research and Training in Tropical Diseases.
39. Wynn T.A., Cheever A.W. Cytokine regulation of granuloma formation in schistosomiasis. Curr. Opin. Immunol. 1995, 7:505-511.
40. Wynn T.A., Cheever A.W., Williams M.E., Hieny S., Caspar P., Kühn R., Müller W., Sher A. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J. Immunol. 1998, 160:4473-4480.
41. Yang W., Jones M.K., Fan J., Hughes-Stamm S.R., McManus D.P. Characterisation of a family of Schistosoma japonicum proteins related to dynein light chains. Biochim. Biophys. Acta 1999, 1432:13-26.
42. Zhang M., Hong Y., Han Y., Han H., Peng J., Qiu C., Yang J., Lu K., Fu Z., Lin J. Proteomic analysis of tegument-exposed proteins of female and male Schistosoma japonicum worms. J Proteome Res 2013, 12:5260-5270.
43. Zhang L.H., McManus D.P., Sunderland P., Lu X.M., Ye J.J., Loukas A., Jones M.K. The cellular distribution and stage-specific expression of two dynein light chains from the human blood fluke Schistosoma japonicum. Int. J. Biochem. Cell Biol. 2005, 37:1511-1524.
44. Zhang Y., Taylor M.G., Bickle Q.D. Schistosoma japonicum myosin: cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5. Parasite Immunol. 1998, 20:583-594.
45. Zhang Z., Xu H., Gan W., Zeng S., Hu X. Schistosoma japonicum calcium-binding tegumental protein SjTP22.4 immunization confers praziquantel schistosomulumicide and antifecundity effect in mice. Vaccine 2012, 30:5141-5150.